Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 64.32 Million MYR | -13.33% |
| 2022 | 688.71 Million MYR | -42.67% |
| 2021 | 1.2 Billion MYR | 71.9% |
| 2020 | 698.78 Million MYR | 68.2% |
| 2019 | 415.45 Million MYR | 26.74% |
| 2018 | 327.79 Million MYR | 14.76% |
| 2017 | 285.64 Million MYR | 35.16% |
| 2016 | 211.33 Million MYR | -3.1% |
| 2015 | 218.1 Million MYR | 4.38% |
| 2014 | 208.95 Million MYR | 25.33% |
| 2013 | 166.72 Million MYR | -3.33% |
| 2012 | 172.46 Million MYR | 70.88% |
| 2011 | 100.92 Million MYR | -23.73% |
| 2010 | 132.33 Million MYR | -6.54% |
| 2009 | 141.59 Million MYR | 69.17% |
| 2008 | 83.7 Million MYR | 1.94% |
| 2007 | 82.11 Million MYR | 20.18% |
| 2006 | 68.32 Million MYR | 45.29% |
| 2005 | 47.02 Million MYR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 5.2 Million MYR | 7.6% |
| 2024 Q1 | 549.38 Million MYR | 134.83% |
| 2024 Q2 | 2.22 Million MYR | 7.74% |
| 2023 Q3 | 643.6 Million MYR | -15.41% |
| 2023 Q2 | 760.82 Million MYR | -2.73% |
| 2023 FY | 596.93 Million MYR | -13.33% |
| 2023 Q1 | 782.16 Million MYR | 123.04% |
| 2023 Q4 | -1.57 Billion MYR | -345.05% |
| 2022 Q4 | -3.39 Billion MYR | -338.51% |
| 2022 Q2 | 1.33 Billion MYR | 0.97% |
| 2022 Q1 | 1.32 Billion MYR | 136.06% |
| 2022 FY | 688.71 Million MYR | -42.67% |
| 2022 Q3 | 1.42 Billion MYR | 6.49% |
| 2021 Q4 | -3.67 Billion MYR | -335.52% |
| 2021 Q3 | 1.55 Billion MYR | -4.99% |
| 2021 Q2 | 1.64 Billion MYR | -1.34% |
| 2021 Q1 | 1.66 Billion MYR | 161.42% |
| 2021 FY | 1.2 Billion MYR | 71.9% |
| 2020 Q3 | 1.25 Billion MYR | 16.48% |
| 2020 Q4 | -2.7 Billion MYR | -315.15% |
| 2020 Q1 | 1.06 Billion MYR | 138.3% |
| 2020 FY | 698.78 Million MYR | 68.2% |
| 2020 Q2 | 1.08 Billion MYR | 1.21% |
| 2019 Q1 | 1.1 Billion MYR | 148.47% |
| 2019 Q2 | 1.01 Billion MYR | -7.94% |
| 2019 Q3 | 1.08 Billion MYR | 7.04% |
| 2019 FY | 415.45 Million MYR | 26.74% |
| 2019 Q4 | -2.78 Billion MYR | -356.65% |
| 2018 Q3 | 953.24 Million MYR | 14.4% |
| 2018 Q4 | -2.27 Billion MYR | -338.55% |
| 2018 Q2 | 833.28 Million MYR | 2.21% |
| 2018 Q1 | 815.25 Million MYR | 142.2% |
| 2018 FY | 327.79 Million MYR | 14.76% |
| 2017 Q1 | 693.8 Million MYR | 143.79% |
| 2017 FY | 285.64 Million MYR | 35.16% |
| 2017 Q4 | -1.93 Billion MYR | -348.81% |
| 2017 Q3 | 776.54 Million MYR | 3.9% |
| 2017 Q2 | 747.39 Million MYR | 7.72% |
| 2016 FY | 211.33 Million MYR | -3.1% |
| 2016 Q1 | 635.86 Million MYR | 147.28% |
| 2016 Q3 | 597.89 Million MYR | 6.65% |
| 2016 Q4 | -1.58 Billion MYR | -365.02% |
| 2016 Q2 | 560.6 Million MYR | -11.84% |
| 2015 Q4 | -1.34 Billion MYR | -340.37% |
| 2015 Q3 | 559.51 Million MYR | 12.21% |
| 2015 Q2 | 498.61 Million MYR | -1.23% |
| 2015 FY | 218.1 Million MYR | 4.38% |
| 2015 Q1 | 504.84 Million MYR | 138.21% |
| 2014 Q3 | 519.63 Million MYR | 4.44% |
| 2014 Q2 | 497.54 Million MYR | -2.92% |
| 2014 Q1 | 512.49 Million MYR | 135.99% |
| 2014 FY | 208.95 Million MYR | 25.33% |
| 2014 Q4 | -1.32 Billion MYR | -354.26% |
| 2013 FY | 166.72 Million MYR | -3.33% |
| 2013 Q2 | 515.21 Million MYR | 0.19% |
| 2013 Q4 | -1.42 Billion MYR | -353.69% |
| 2013 Q1 | 514.25 Million MYR | 137.79% |
| 2013 Q3 | 561.35 Million MYR | 8.96% |
| 2012 Q3 | 539.64 Million MYR | 12.36% |
| 2012 FY | 172.46 Million MYR | 70.88% |
| 2012 Q1 | 513.18 Million MYR | 139.44% |
| 2012 Q2 | 480.27 Million MYR | -6.41% |
| 2012 Q4 | -1.36 Billion MYR | -352.14% |
| 2011 Q3 | 500.99 Million MYR | 10.35% |
| 2011 Q4 | -1.3 Billion MYR | -359.73% |
| 2011 Q2 | 454.01 Million MYR | 0.0% |
| 2011 FY | 100.92 Million MYR | -23.73% |
| 2010 FY | 132.33 Million MYR | -6.54% |
| 2009 FY | 141.59 Million MYR | 69.17% |
| 2008 FY | 83.7 Million MYR | 1.94% |
| 2007 FY | 82.11 Million MYR | 20.18% |
| 2006 FY | 68.32 Million MYR | 45.29% |
| 2005 FY | 47.02 Million MYR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -2146.338% |
| Ansell Limited | 495.5 Million USD | 87.019% |
| Ansell Limited | 495.5 Million USD | 87.019% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 22.322% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -3616.295% |
| Psykey, Inc. | 1.21 Million USD | -5200.458% |
| ConvaTec Group Plc | 910.31 Million USD | 92.934% |
| ConvaTec Group Plc | 872.5 Million USD | 92.628% |
| Encision Inc. | 3.77 Million USD | -1603.054% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -45256.143% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -58409.429% |
| Innovative MedTech Inc. | 6.09 Million USD | -954.599% |
| LifePoint, Inc. | 7.42 Million USD | -766.394% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -913.073% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -7422.807% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -8757.869% |
| Reflect Scientific, Inc. | 1.06 Million USD | -5946.823% |
| SmileDirectClub, Inc. | 517 Million USD | 87.559% |
| Sector 10, Inc. | 39.84 Thousand USD | -161329.575% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.032% |
| SheerVision, Inc. | 2.33 Million USD | -2658.579% |
| United Health Products, Inc. | 2.42 Million USD | -2550.689% |
| Vasamed, Inc. | 4.67 Million USD | -1276.443% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -2410.731% |
| Yubo International Biotech Limited | 1.25 Million USD | -5013.386% |